A phase 1/2 study of carfilzomib in combination with lenalidomide and low-dose dexamethasone as a frontline treatment for multiple myeloma (Q33401596)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | A phase 1/2 study of carfilzomib in combination with lenalidomide and low-dose dexamethasone as a frontline treatment for multiple myeloma |
scientific article |
Statements
1 reference
A phase 1/2 study of carfilzomib in combination with lenalidomide and low-dose dexamethasone as a frontline treatment for multiple myeloma (English)
1 reference
Keith Stockerl-Goldstein
1 reference
Andrzej J Jakubowiak
1 reference
Dominik Dytfeld
1 reference
Kent A Griffith
1 reference
Daniel Lebovic
1 reference
David H Vesole
1 reference
Sundar Jagannath
1 reference
Ammar Al-Zoubi
1 reference
Tara Anderson
1 reference
Brian Nordgren
1 reference
Kristen Detweiler-Short
1 reference
Asra Ahmed
1 reference
Terri Jobkar
1 reference
Diane E Durecki
1 reference
Kathryn McDonnell
1 reference
Melissa Mietzel
1 reference
Daniel Couriel
1 reference
Mark Kaminski
1 reference
Ravi Vij
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference